ABBV – abbvie inc. (US:NASDAQ)
Stock Stats
News
11/22
07:34 am
abbv
Low
AbbVie Inc. (NYSE: ABBV) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $206.00 price target on the stock.
11/22
07:15 am
abbv
Low
Antibody Drug Conjugates Contract Manufacturing Market Analysis and Forecast (2025-2030) by Linker, Condition, End Use and Region - Industry Set to Experience 11.8% CAGR Over the Forecast Period [Yahoo! Finance]
11/21
06:28 am
abbv
Low
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy [Yahoo! Finance]
11/20
11:19 am
abbv
Low
Specialty Pharmaceuticals Research Report: Increased Reimbursement Through Medical and Pharmacy Benefits Driving the Market, Reaching $965 Billion by 2030 [Yahoo! Finance]
11/20
10:12 am
abbv
Low
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? [Yahoo! Finance]
10/30/2024
07:38 am
abbv
6.1%
BEAT
7/25/2024
07:36 am
abbv
3.9%
BEAT
4/26/2024
07:35 am
abbv
-5.0%
MISS
2/2/2024
07:36 am
abbv
0.3%
BEAT
11/22
07:43 am
Upgrades
Market Perform
Outperform
Leerink Partners
Low
2.6%
11/22
07:34 am
Upgrades
Market Perform
Outperform
Leerink Partners
Low
2.5%
11/15
08:04 am
Initiates
Outperform
Wolfe Research
Low
-3.0%
11/15
08:04 am
Initiates
Outperform
Wolfe Research
Low
-3.0%
11/15
05:08 am
Initiates
Outperform
Wolfe Research
Low
-2.6%
11/4
04:17 pm
abbv
Low
Form S-8 AbbVie Inc.
11/4
04:16 pm
abbv
Low
Form S-8 AbbVie Inc.
11/4
02:20 pm
abbv
Low
Form 10-Q AbbVie Inc. For: Sep 30
10/30
07:43 am
abbv
Medium
Form 8-K AbbVie Inc. For: Oct 30
10/3
04:07 pm
abbv
Low
Form 8-K AbbVie Inc. For: Oct 03
Show more
Top News Gainers
3/26 Form PX14A6G AbbVie Inc. Filed by: United Church Funds, Inc. 9.7%
3/3 Form 4 AbbVie Inc. For: Feb 28 Filed by: Schumacher Laura J 4.8%
3/19 Israel OKs use of generic AbbVie drug to treat coronavirus despite patent [Reuters (UK)] 4.7%
2/7 Q4/2019 12/31/2019 EPS 2.210 ZacksConsensus 2.200 ActVsEst 0.010 - Beat 4.6%
3/23 Abbvie: Buy The Coronavirus Dip For These 3 Reasons [Seeking Alpha] 4.5%
6/27 AbbVie: $63 Billion Allergan Acquisition Just What The Doctor Ordered [Seeking Alpha] 3.7%
6/25 AbbVie Inc. (ABBV) CEO Rick Gonzalez on Acquisition of Allergan Conference Call (Transcript) [Seeking Alpha] 3.6%
11/8 AbbVie Submits Supplemental New Drug Application to U.S. FDA For IMBRUVICA® (ibrutinib) in Combination with Rituximab for the Treatment of Previously Untreated, Younger Adults with Chronic Lymphocytic Leukemia 3.6%
8/16 Form 4 AbbVie Inc. For: Aug 14 Filed by: Gosebruch Henry O 3.3%
6/26 AbbVie Inc (NYSE: ABBV) had its "hold" rating re-affirmed by analysts at Citigroup Inc. 3.2%
Top News Decliners
6/25 AbbVie nears deal to buy Allergan for more than $60 bln - WSJ [Reuters] -11.8%
3/20 Form 4 AbbVie Inc. For: Mar 18 Filed by: Durkin Brian L -6.5%
3/12 AbbVie Receives European Commission Approval of VENCLYXTO® Combination Regimen for Patients with Previously-Untreated Chronic Lymphocytic Leukemia -4.1%
2/24 Form 4 AbbVie Inc. For: Feb 20 Filed by: Durkin Brian L -3.9%
10/1 Lanny's October Dividend Stock Watch List [Seeking Alpha] -3.6%
3/10 Generic anti-malarial may treat COVID-19 - Raymond James [Seeking Alpha] -3.0%
2/27 AbbVie Inc (NYSE: ABBV) is now covered by analysts at Barclays PLC. They set an "equal weight" rating on the stock. -2.9%
3/17 AbbVie and Allergan Sign Consent Decree Agreement with Federal Trade Commission Staff on Pending Transaction -2.7%
4/7 Form PX14A6G AbbVie Inc. Filed by: ZEVIN ASSET MANAGEMENT LLC -2.6%
2/12 Results from Chinese drug trials for coronavirus due in weeks: expert [Reuters (UK)] -2.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3